GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (FRA:AEQ) » Definitions » Non Operating Income

Aequus Pharmaceuticals (FRA:AEQ) Non Operating Income : €0.02 Mil (TTM As of Sep. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Aequus Pharmaceuticals Non Operating Income?

Non Operating Income is income or expense that comes from miscellaneous sources. Aequus Pharmaceuticals's Non Operating Income for the three months ended in Sep. 2024 was €0.00 Mil. Its Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 was €0.02 Mil.

Aequus Pharmaceuticals Non Operating Income Historical Data

The historical data trend for Aequus Pharmaceuticals's Non Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals Non Operating Income Chart

Aequus Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Non Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.33 - - -0.36 -

Aequus Pharmaceuticals Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Non Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 0.03 -

Aequus Pharmaceuticals Non Operating Income Calculation

Non Operating Income is income or expense that comes from miscellaneous sources.

Non Operating Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aequus Pharmaceuticals Non Operating Income Related Terms

Thank you for viewing the detailed overview of Aequus Pharmaceuticals's Non Operating Income provided by GuruFocus.com. Please click on the following links to see related term pages.

Aequus Pharmaceuticals Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (FRA:AEQ) » Definitions » Non Operating Income
Comparable Companies
XCNQ:JOLT XCNQ:MYCO TSX:WLLW XCNQ:CNTR XCNQ:STKT XCNQ:PLCN XCNQ:VIBE XCNQ:GHG XCNQ:XCX XCNQ:LOWL ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
AQSZF:USA AQS:Canada
Address
200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4
Website
https://www.aequuspharma.ca
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.

Aequus Pharmaceuticals Headlines

No Headlines